...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

From the press release . “Harnessing epigenetic modulation may be a potent tool in slowing down COVID-19 virus spread and disease severity..."

If this holds true Apabetalone could potentially turn this pandemic into a really bad flu season and allow for society to return to something closer to normalcy. Yesterday I saw Donald Trump talking about getting America back to work on a schedule much tighter than most were thinking could be safely possible. Could Apabetalone be Tump's magic bullet?

I hope RVX management can bring a heightened game which they have thus far never demonstrated they have. 

Share
New Message
Please login to post a reply